Live from the NIH registry
Studies recruiting near Pensacola right now
Top 25 of 134 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 315 participants sought
Child Neurology of NW Florida — Gulf Breeze, Florida (6.0 mi)
· Sponsor: H. Lundbeck A/S
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Ascension Sacred Heart — Pensacola, Florida (2.1 mi)
· Sponsor: Hoffmann-La Roche
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Baptist Hospital Cardiology — Pensacola, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
Retina Specialty Institute — Pensacola, Florida (2.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Ascension Sacred Heart — Pensacola, Florida (2.1 mi)
· Sponsor: Amgen
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Northwest Florida Clinical Research Group, LLC /ID# 251382 — Gulf Breeze, Florida (6.0 mi)
· Sponsor: AbbVie
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Northwest Florida Clinical Research Group, Merz Investigational Site #0010286 — Gulf Breeze, Florida (6.0 mi)
· Sponsor: Merz Therapeutics GmbH
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Phase 2
Interventional 175 participants sought
AHF - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Gilead Sciences
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Sleep Apnea, Obstructive, Obesity
Phase 3
Interventional 800 participants sought
Emerald Coast Neurology - Airport Boulevard — Pensacola, Florida (2.1 mi)
· Sponsor: Eli Lilly and Company
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Emerald Coast Neurology - Airport Boulevard — Pensacola, Florida (2.1 mi)
· Sponsor: Eli Lilly and Company
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Sacred Heart Hospital — Pensacola, Florida (2.1 mi)
· Sponsor: NRG Oncology
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Nemours Children's Clinic - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Children's Oncology Group
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Dravet Syndrome
Phase 3
Interventional 160 participants sought
NW FL Clinical Research Group, LLC — Gulf Breeze, Florida (6.0 mi)
· Sponsor: Longboard Pharmaceuticals
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Southern Cancer Center, PC — Foley, Alabama (29.4 mi)
· Sponsor: Pfizer
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Migraine
Phase 3
Interventional 600 participants sought
NW FL Clinical Research Group, LLC — Gulf Breeze, Florida (6.0 mi)
· Sponsor: H. Lundbeck A/S
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Foley, Alabama (29.4 mi)
· Sponsor: AstraZeneca
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Gastro Health Research - Pensacola — Pensacola, Florida (2.1 mi)
· Sponsor: Eli Lilly and Company
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
Phase 3
Interventional 350 participants sought
Ep0162 50515 — Gulf Breeze, Florida (6.0 mi)
· Sponsor: UCB Biopharma SRL
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Chronic Myelogenous Leukemia - Chronic Phase
N/A
Observational 1,000 participants sought
Sacred Heart Medical Oncology — Pensacola, Florida (2.1 mi)
· Sponsor: Novartis Pharmaceuticals
Knee Related Subchondral Bone Lesions Treated With IOBP
Subchondral Cyst
N/A
Observational 100 participants sought
Andrews Research and Education Foundation — Gulf Breeze, Florida (6.0 mi)
· Sponsor: Arthrex, Inc.